G Sianos

Summary

Affiliation: Erasmus MC
Country: The Netherlands

Publications

  1. ncbi request reprint Thirty-day incidence and six-month clinical outcome of thrombotic stent occlusion after bare-metal, sirolimus, or paclitaxel stent implantation
    Andrew T L Ong
    Thoraxcenter, Erasmus Medical Center, Rotterdam, The Netherlands
    J Am Coll Cardiol 45:947-53. 2005
  2. ncbi request reprint European experience with the retrograde approach for the recanalisation of coronary artery chronic total occlusions. A report on behalf of the euroCTO club
    Georgios Sianos
    Erasmus MC, Thoraxcenter, Rotterdam, The Netherlands
    EuroIntervention 4:84-92. 2008
  3. ncbi request reprint Angiographic stent thrombosis after routine use of drug-eluting stents in ST-segment elevation myocardial infarction: the importance of thrombus burden
    Georgios Sianos
    Erasmus Medical Center, Department of Interventional Cardiology, Thoraxcenter, Rotterdam, The Netherlands
    J Am Coll Cardiol 50:573-83. 2007
  4. ncbi request reprint Rheolytic thrombectomy in patients with ST-elevation myocardial infarction and large thrombus burden: the Thoraxcenter experience
    Georgios Sianos
    Erasmus Medical Center, Department of Interventional Cardiology, Thoraxcenter, Rotterdam, The Netherlands
    J Invasive Cardiol 18:3C-7C. 2006
  5. ncbi request reprint Images in cardiovascular medicine. Hypertrophic obstructive cardiomyopathy: septal ablation with overlapping sirolimus-eluting and covered stents after failed alcoholization and concomitant coronary artery disease
    Georgios Sianos
    Department of Cardiology, Thoraxcenter, Erasmus Medical Center, Dr Molewaterplein 40, 3015 GD, Rotterdam, The Netherlands
    Circulation 114:e553-5. 2006
  6. ncbi request reprint Bifurcation stenting with drug eluting stents: illustration of the crush technique
    Georgios Sianos
    Department of Interventional Cardiology, Thoraxcenter, Erasmus Medical Center, Rotterdam, The Netherlands
    Catheter Cardiovasc Interv 67:839-45. 2006
  7. pmc Long term outcome after intracoronary beta radiation therapy
    G Sianos
    Department of Interventional Cardiology, Thoraxcentre, Erasmus MC, Rotterdam, The Netherlands
    Heart 91:942-7. 2005
  8. doi request reprint Long-term clinical results following stenting of the left main stem: insights from RESEARCH (Rapamycin-Eluting Stent Evaluated at Rotterdam Cardiology Hospital) and T-SEARCH (Taxus-Stent Evaluated at Rotterdam Cardiology Hospital) Registries
    Yoshinobu Onuma
    Thoraxcenter, Erasmus Medical Center, Rotterdam, The Netherlands
    JACC Cardiovasc Interv 3:584-94. 2010
  9. ncbi request reprint Radioactive stents delay but do not prevent in-stent neointimal hyperplasia
    I P Kay
    Thoraxcenter, University Hospital Rotterdam, Dijkzigt, The Netherlands
    Circulation 103:14-7. 2001
  10. doi request reprint Three-year survival following multivessel percutaneous coronary intervention with bare-metal or drug-eluting stents in unselected patients
    Neville Kukreja
    Thoraxcenter, Erasmus Medical Center, Rotterdam, The Netherlands
    Am J Cardiol 103:203-11. 2009

Detail Information

Publications80

  1. ncbi request reprint Thirty-day incidence and six-month clinical outcome of thrombotic stent occlusion after bare-metal, sirolimus, or paclitaxel stent implantation
    Andrew T L Ong
    Thoraxcenter, Erasmus Medical Center, Rotterdam, The Netherlands
    J Am Coll Cardiol 45:947-53. 2005
    ....
  2. ncbi request reprint European experience with the retrograde approach for the recanalisation of coronary artery chronic total occlusions. A report on behalf of the euroCTO club
    Georgios Sianos
    Erasmus MC, Thoraxcenter, Rotterdam, The Netherlands
    EuroIntervention 4:84-92. 2008
    ..Recanalisation rates of coronary chronic total occlusions (CTO) remain sub-optimal. The retrograde technique was recently introduced to improve success rates...
  3. ncbi request reprint Angiographic stent thrombosis after routine use of drug-eluting stents in ST-segment elevation myocardial infarction: the importance of thrombus burden
    Georgios Sianos
    Erasmus Medical Center, Department of Interventional Cardiology, Thoraxcenter, Rotterdam, The Netherlands
    J Am Coll Cardiol 50:573-83. 2007
    ....
  4. ncbi request reprint Rheolytic thrombectomy in patients with ST-elevation myocardial infarction and large thrombus burden: the Thoraxcenter experience
    Georgios Sianos
    Erasmus Medical Center, Department of Interventional Cardiology, Thoraxcenter, Rotterdam, The Netherlands
    J Invasive Cardiol 18:3C-7C. 2006
    ..To determine the impact of Rheolytic thrombectomy (RT) on the clinical and angiographic outcome of patients with ST-elevation myocardial infarction (STEMI) and large thrombus burden (LTB)...
  5. ncbi request reprint Images in cardiovascular medicine. Hypertrophic obstructive cardiomyopathy: septal ablation with overlapping sirolimus-eluting and covered stents after failed alcoholization and concomitant coronary artery disease
    Georgios Sianos
    Department of Cardiology, Thoraxcenter, Erasmus Medical Center, Dr Molewaterplein 40, 3015 GD, Rotterdam, The Netherlands
    Circulation 114:e553-5. 2006
  6. ncbi request reprint Bifurcation stenting with drug eluting stents: illustration of the crush technique
    Georgios Sianos
    Department of Interventional Cardiology, Thoraxcenter, Erasmus Medical Center, Rotterdam, The Netherlands
    Catheter Cardiovasc Interv 67:839-45. 2006
    ..The purpose of the present report is to review three cases treated with crush stenting and to describe in detail the technique and its variations...
  7. pmc Long term outcome after intracoronary beta radiation therapy
    G Sianos
    Department of Interventional Cardiology, Thoraxcentre, Erasmus MC, Rotterdam, The Netherlands
    Heart 91:942-7. 2005
    ..To determine the long term outcome after intracoronary beta radiation therapy (IRT)...
  8. doi request reprint Long-term clinical results following stenting of the left main stem: insights from RESEARCH (Rapamycin-Eluting Stent Evaluated at Rotterdam Cardiology Hospital) and T-SEARCH (Taxus-Stent Evaluated at Rotterdam Cardiology Hospital) Registries
    Yoshinobu Onuma
    Thoraxcenter, Erasmus Medical Center, Rotterdam, The Netherlands
    JACC Cardiovasc Interv 3:584-94. 2010
    ....
  9. ncbi request reprint Radioactive stents delay but do not prevent in-stent neointimal hyperplasia
    I P Kay
    Thoraxcenter, University Hospital Rotterdam, Dijkzigt, The Netherlands
    Circulation 103:14-7. 2001
    ..Clinical outcome 1 year after the implantation of stents with an initial activity of 6 to 12 microCi is not favorable when compared with conventional stenting...
  10. doi request reprint Three-year survival following multivessel percutaneous coronary intervention with bare-metal or drug-eluting stents in unselected patients
    Neville Kukreja
    Thoraxcenter, Erasmus Medical Center, Rotterdam, The Netherlands
    Am J Cardiol 103:203-11. 2009
    ..SESs might reduce mortality in patients undergoing multivessel percutaneous coronary intervention...
  11. pmc Routine sirolimus eluting stent implantation for unselected in-stent restenosis: insights from the rapamycin eluting stent evaluated at Rotterdam Cardiology Hospital (RESEARCH) registry
    F Saia
    Department of Invasive Cardiology, Thoraxcentre, Erasmus University Medical Centre, Rotterdam, The Netherlands
    Heart 90:1183-8. 2004
    ....
  12. ncbi request reprint The pattern of restenosis and vascular remodelling after cold-end radioactive stent implantation
    I P Kay
    Thoraxcenter, Rotterdam, The Netherlands
    Eur Heart J 22:1311-7. 2001
    ..0%) and 11.4 mm3 (25.6%), respectively (P=0.017). At the stent edges there was no significant change in lumen volume. CONCLUSIONS: Cold-end stenting results in increased neointimal hyperplasia in in-stent non-radioactive segments...
  13. ncbi request reprint Sonotherapy, antirestenotic therapeutic ultrasound in coronary arteries: the first clinical experience
    E Regar
    Department of Cardiology, Thoraxcentre, Erasmus Medical Center Rotterdam, Rotterdam, The Netherlands
    Catheter Cardiovasc Interv 60:9-17. 2003
    ..Sonotherapy-related major adverse events were not observed. Late lumen loss and neointimal growth were similar to conventional PTCA approaches. These results justify the initiation of randomized clinical efficacy studies...
  14. ncbi request reprint Comparison of three-year clinical outcome of sirolimus- and paclitaxel-eluting stents versus bare metal stents in patients with ST-segment elevation myocardial infarction (from the RESEARCH and T-SEARCH Registries)
    Joost Daemen
    Thoraxcenter, Erasmus Medical Center, Rotterdam, The Netherlands
    Am J Cardiol 99:1027-32. 2007
    ..A high frequency of stent thrombosis was observed in the 2 drug-eluting stent groups...
  15. doi request reprint The risk of stent thrombosis in patients with acute coronary syndromes treated with bare-metal and drug-eluting stents
    Neville Kukreja
    Thoraxcenter, Erasmus Medical Center, Rotterdam, The Netherlands
    JACC Cardiovasc Interv 2:534-41. 2009
    ..We aimed to evaluate the risk of definite stent thrombosis with bare-metal stents (BMS) and drug-eluting stents (DES) in patients treated for acute coronary syndromes...
  16. ncbi request reprint Geographical miss during catheter-based intracoronary beta-radiation: incidence and implications in the BRIE study. Beta-Radiation In Europe
    G Sianos
    Department of Cardiology, Thoraxcenter, Erasmus Medical Center Rotterdam, The Netherlands
    J Am Coll Cardiol 38:415-20. 2001
    ..6%, respectively, p = 0.8). CONCLUSIONS: Geographical miss is strongly associated with restenosis at the edges of the EIRS. This effect is more prominent when caused by stenting. Geographical miss does not increase restenosis in the EIRS...
  17. ncbi request reprint Post-sirolimus-eluting stent restenosis treated with repeat percutaneous intervention: late angiographic and clinical outcomes
    Pedro A Lemos
    Erasmus Medical Center, Thoraxcenter, Rotterdam, The Netherlands
    Circulation 109:2500-2. 2004
    ..We evaluated the clinical and angiographic outcomes of patients presenting with restenosis after sirolimus-eluting stent (SES) implantation treated with repeated percutaneous intervention...
  18. ncbi request reprint Sirolimus-eluting coronary stents
    P J de Feyter
    Thoraxcenter, Room Bd 410, Erasmus Medical Centre, Dr Molewaterplein 40, 3015 GD Rotterdam, The Netherlands
    J Interv Cardiol 15:467-70. 2002
  19. ncbi request reprint Stent development and local drug delivery
    E Regar
    Department of Cardiology, Thoraxcentre, Erasmus Medical Centre Rotterdam, The Netherlands
    Br Med Bull 59:227-48. 2001
    ..The clinical benefit of these approaches still has to be proven...
  20. ncbi request reprint Value of coronary stenotic flow velocity acceleration on the prediction of long-term improvement in functional status after angioplasty
    M Albertal
    Thoraxcenter, Amsterdam, The Netherlands
    Am Heart J 142:81-6. 2001
    ..03 to 1.07) were associated with a lack of improvement at follow-up. CONCLUSIONS: The detection of SVA was associated with failure of improvement in functional activity at follow-up after coronary intervention...
  21. ncbi request reprint Multislice spiral computed tomography for the evaluation of stent patency after left main coronary artery stenting: a comparison with conventional coronary angiography and intravascular ultrasound
    Carlos A G van Mieghem
    Department of Cardiology, Thoraxcenter, Erasmus MC, Rotterdam, The Netherlands
    Circulation 114:645-53. 2006
    ..Multislice computed tomography (MSCT) is a promising technique for noninvasive coronary evaluation. We evaluated the diagnostic performance of high-resolution MSCT to detect ISR after stenting of the LMCA...
  22. ncbi request reprint Clinical and angiographic outcomes after overdilatation of undersized sirolimus-eluting stents with largely oversized balloons: an observational study
    Francesco Saia
    Erasmus MC, Thoraxcenter, Rotterdam, The Netherlands
    Catheter Cardiovasc Interv 61:455-60. 2004
    ..13 +/- 0.34 and restenosis rate was 7.7%. Although not routinely recommended in every patient, SES postdilatation with largely oversized balloons appears a safe and effective strategy for selected patients...
  23. ncbi request reprint Significant reduction in restenosis after the use of sirolimus-eluting stents in the treatment of chronic total occlusions
    Angela Hoye
    Department of Interventional Cardiology, Erasmus MC, Rotterdam, The Netherlands
    J Am Coll Cardiol 43:1954-8. 2004
    ..The aim of this study was to assess sirolimus-eluting stent (SES) implantation for the treatment of chronic total coronary occlusions (CTO)...
  24. ncbi request reprint The unrestricted use of paclitaxel- versus sirolimus-eluting stents for coronary artery disease in an unselected population: one-year results of the Taxus-Stent Evaluated at Rotterdam Cardiology Hospital (T-SEARCH) registry
    Andrew T L Ong
    Thoraxcenter, Erasmus Medical Center, Dr Molewaterplein 40, 3015 GD Rotterdam, The Netherlands
    J Am Coll Cardiol 45:1135-41. 2005
    ..We investigated the efficacy of paclitaxel-eluting stents (PES) compared to sirolimus-eluting stents (SES) when used without restriction in unselected patients...
  25. ncbi request reprint Long-term outcomes after stenting of bifurcation lesions with the "crush" technique: predictors of an adverse outcome
    Angela Hoye
    Thoraxcenter, Erasmus Medical Center, Rotterdam, The Netherlands
    J Am Coll Cardiol 47:1949-58. 2006
    ..The purpose of this study was to evaluate predictors of an adverse outcome after "crush" bifurcation stenting...
  26. pmc One year clinical follow up of paclitaxel eluting stents for acute myocardial infarction compared with sirolimus eluting stents
    S H Hofma
    Thoraxcentre, Erasmus Medical Centre, Rotterdam, The Netherlands
    Heart 91:1176-80. 2005
    ..To compare clinical outcome of paclitaxel eluting stents (PES) versus sirolimus eluting stents (SES) for the treatment of acute ST elevation myocardial infarction...
  27. ncbi request reprint Intracoronary beta-radiation to reduce restenosis after balloon angioplasty and stenting; the Beta Radiation In Europe (BRIE) study
    P W Serruys
    Department of Interventional Cardiology, Thoraxcenter, Heartcenter, Erasmus Medical Center, Academisch Ziekenhuis Dijkzigt Rotterdam, The Netherlands
    Eur Heart J 23:1351-9. 2002
    ..The BRIE trial is a registry evaluating the safety and performance of (90)Sr delivered locally (Beta-Cath TM system of Novoste) to de-novo and restenotic lesions in patients with up to two discrete lesions in different vessels...
  28. ncbi request reprint Percutaneous therapy of bifurcation lesions with drug-eluting stent implantation: the Culotte technique revisited
    Angela Hoye
    Thoraxcenter, Erasmus Medical Center, Rotterdam, The Netherlands
    Int J Cardiovasc Intervent 7:36-40. 2005
    ..Drug-eluting stents reduce the rate of restenosis and need for repeat lesion revascularization compared with bare metal stents; we re-evaluated this technique with drug-eluting stent implantation...
  29. ncbi request reprint Coronary restenosis after sirolimus-eluting stent implantation: morphological description and mechanistic analysis from a consecutive series of cases
    Pedro A Lemos
    Erasmus Medical Center, Thoraxcenter, Bd 406, Dr Molewaterplein 40, 3015 GD Rotterdam, The Netherlands
    Circulation 108:257-60. 2003
    ..We describe the clinical and morphological patterns of restenosis after sirolimus-eluting stent (SES) implantation...
  30. ncbi request reprint Three-year clinical follow-up of the unrestricted use of sirolimus-eluting stents as part of the Rapamycin-Eluting Stent Evaluated at Rotterdam Cardiology Hospital (RESEARCH) registry
    Joost Daemen
    The Thoraxcenter, Erasmus Medical Center, Rotterdam, The Netherlands
    Am J Cardiol 98:895-901. 2006
    ..The beneficial effects, reported after 1 and 2 years in reducing major adverse cardiac events, persisted with no evidence of a clinical late restenotic "catch-up" phenomenon...
  31. ncbi request reprint Chronic total occlusion treatment in post-CABG patients: saphenous vein graft versus native vessel recanalization-long-term follow-up in the drug-eluting stent era
    Emanuele Meliga
    Interventional Cardiology Department, Thoraxcenter, Erasmus University Medical Center Rotterdam, Rotterdam, The Netherlands
    Catheter Cardiovasc Interv 70:21-5. 2007
    ..To compare the postprocedural and long-term clinical outcomes of two groups of patients, all presenting with chronic saphenous vein graft (SVG) occlusion, who underwent either SVG or native vessel reopening...
  32. ncbi request reprint Sirolimus-eluting stent implantation in ST-elevation acute myocardial infarction: a clinical and angiographic study
    Francesco Saia
    Department of Interventional Cardiology, Thoraxcenter, Erasmus Medical Center, Rotterdam, The Netherlands
    Circulation 108:1927-9. 2003
    ..Sirolimus-eluting stents (SES) have recently been proven to reduce restenosis and reintervention compared with bare stents. Safety and effectiveness of SES in acute myocardial infarction remain unknown...
  33. ncbi request reprint Images in cardiovascular medicine. Late-late occlusion after intracoronary brachytherapy
    Georgios Sianos
    Department of Interventional Cardiology, Thoraxcenter, Erasmus Medical Center, Rotterdam, The Netherlands
    Circulation 108:e69-70. 2003
  34. ncbi request reprint Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: data from a large two-institutional cohort study
    Joost Daemen
    Department of Cardiology, Thoraxcenter, Erasmus Medical Center, Dr Molewaterplein 40, 3015 GD Rotterdam, Netherlands
    Lancet 369:667-78. 2007
    ..Stent thrombosis is a safety concern associated with use of drug-eluting stents. Little is known about occurrence of stent thrombosis more than 1 year after implantation of such stents...
  35. ncbi request reprint The long-term value of sirolimus- and paclitaxel-eluting stents over bare metal stents in patients with diabetes mellitus
    Joost Daemen
    Thoraxcenter, Erasmus Medical Center, Ba 583 Dr Molewaterplein 40, 3015 GD Rotterdam, The Netherlands
    Eur Heart J 28:26-32. 2007
    ..Due to the different mechanisms of action of both drugs it is currently unknown which device is the best option to treat these high-risk patients...
  36. ncbi request reprint Clinical, angiographic, and procedural predictors of angiographic restenosis after sirolimus-eluting stent implantation in complex patients: an evaluation from the Rapamycin-Eluting Stent Evaluated At Rotterdam Cardiology Hospital (RESEARCH) study
    Pedro A Lemos
    Erasmus Medical Center, Thoraxcenter, Rotterdam, The Netherlands
    Circulation 109:1366-70. 2004
    ..The factors associated with the occurrence of restenosis after sirolimus-eluting stent (SES) implantation in complex cases are currently unknown...
  37. ncbi request reprint Comparison of short- (one month) and long- (twelve months) term outcomes of sirolimus- versus paclitaxel-eluting stents in 293 consecutive patients with diabetes mellitus (from the RESEARCH and T-SEARCH registries)
    Andrew T L Ong
    Thoraxcenter, Erasmus Medical Center, Rotterdam, The Netherlands
    Am J Cardiol 96:358-62. 2005
    ..Patients who required insulin had a significantly higher, crude major adverse cardiac event rate at 1 year compared with those who used oral agents, but this rate became nonsignificant when adjusted for independent predictors of outcome...
  38. ncbi request reprint One-year clinical outcome after coronary stenting of very small vessels using 2.25 mm sirolimus- and paclitaxel-eluting stents: a comparison between the RESEARCH and T-SEARCH registries
    Gaston A Rodriguez-Granillo
    Cardiac Catheterization Laboratory, Thoraxcenter, Erasmus Medical Center, Rotterdam, Kamer Z 120, Dr Molewaterplein 40, Rotterdam, The Netherlands 3015 GD
    J Invasive Cardiol 17:409-12. 2005
    ..The efficacy of sirolimus-eluting stents (SES) compared to paclitaxel-eluting stents (PES) remains unknown. We evaluated the clinical outcomes after implantation of 2.25 mm diameter SES and PES...
  39. ncbi request reprint Restenosis rates following bifurcation stenting with sirolimus-eluting stents for de novo narrowings
    Kengo Tanabe
    Thoraxcenter, Erasmus Medical Center, Rotterdam, The Netherlands
    Am J Cardiol 94:115-8. 2004
    ..At 6 months, the incidence of major adverse cardiac events was 10.3% (1 death and 5 target lesion revascularizations) with no episodes of acute myocardial infarction or stent thrombosis...
  40. ncbi request reprint Treatment of very small vessels with 2.25-mm diameter sirolimus-eluting stents (from the RESEARCH registry)
    Pedro A Lemos
    Department of Cardiology, Thoraxcenter, Erasmus Medical Center Rotterdam, Rotterdam, The Netherlands
    Am J Cardiol 93:633-6. 2004
    ..7% versus 3.9%, respectively (p = 0.1). The 12-month target lesion revascularization rate was 5.5%. In conclusion, 2.25-mm SESs were associated with low rates of clinical and angiographic late complications...
  41. ncbi request reprint Very long sirolimus-eluting stent implantation for de novo coronary lesions
    Muzaffer Degertekin
    Department of Interventional Cardiology, Thoraxcentre, Erasmus MC, Rotterdam, The Netherlands
    Am J Cardiol 93:826-9. 2004
    ..1%), and the overall incidence of major cardiac events was 8.3%. Thus, SES implantation appears safe and effective for de novo coronary lesions requiring multiple stent placement over a very long vessel segment...
  42. ncbi request reprint The efficacy of sirolimus-eluting stents versus bare metal stents for diabetic patients undergoing elective percutaneous coronary intervention
    Jiro Aoki
    Interventional Cardiology, Erasmus Medical Center, Dr Molewaterplein 40, Rotterdam, 3015 GD, The Netherlands
    J Invasive Cardiol 17:344-8. 2005
    ..In this study, the impact of sirolimus-eluting stents (SES) were evaluated in a consecutive group of diabetic patients undergoing elective percutaneous coronary treatment and compared to a population treated with bare metal stents...
  43. doi request reprint The everolimus-eluting stent in real-world patients: 6-month follow-up of the X-SEARCH (Xience V Stent Evaluated at Rotterdam Cardiac Hospital) registry
    Yoshinobu Onuma
    Thoraxcenter, Erasmus Medical Center, Rotterdam, The Netherlands
    J Am Coll Cardiol 54:269-76. 2009
    ....
  44. ncbi request reprint Endothelial progenitor cell capture by stents coated with antibody against CD34: the HEALING-FIM (Healthy Endothelial Accelerated Lining Inhibits Neointimal Growth-First In Man) Registry
    Jiro Aoki
    Thoraxcenter, Erasmus Medical Center, Rotterdam, The Netherlands
    J Am Coll Cardiol 45:1574-9. 2005
    ..This study was designed to evaluate whether rapid endothelialization of stainless steel stents with a functional endothelium prevents stent thrombosis and reduces the restenotic process...
  45. ncbi request reprint Geographical miss during centered intracoronary beta-radiation with 90Yttrium: incidence and implications for recurrence rates after vascular brachytherapy for de novo lesions
    Georgios Sianos
    Thorax Center, Erasmus MC, Rotterdam, The Netherlands
    Int J Cardiovasc Intervent 5:181-9. 2003
    ..The authors sought to determine the incidence and causes of geographical miss (GM) and evaluate its impact on edge restenosis after 'primary', centered, intracoronary beta-radiation therapy...
  46. ncbi request reprint Effectiveness of sirolimus-eluting stent implantation for recurrent in-stent restenosis after brachytherapy
    Francesco Saia
    Erasmus MC, Thoraxcenter, Dr Molewaterplein 40, 3015 GD Rotterdam, The Netherlands
    Am J Cardiol 92:200-3. 2003
  47. ncbi request reprint The black hole: echolucent tissue observed following intracoronary radiation
    I Patrick Kay
    Thoraxcenter, Rotterdam, The Netherlands
    Int J Cardiovasc Intervent 5:137-42. 2003
    ..The authors describe a new observation noted on intravascular ultrasound: that of intraluminal echolucent tissue, dubbed the 'black hole', noted at six-month follow-up...
  48. ncbi request reprint Incidence of thrombotic stent occlusion during the first three months after sirolimus-eluting stent implantation in 500 consecutive patients
    Evelyn Regar
    Department of Cardiology, Thoraxcenter, Erasmus Medical Center Rotterdam, Dr Molewaterplein 40, 3015 GD Rotterdam, The Netherlands
    Am J Cardiol 93:1271-5. 2004
    ..These cases occurred in diabetic women with complex coronary lesions. Intravascular ultrasound examination showed inadequate stent expansion and uncovered distal dissection as possible mechanical explanations for the thrombosis...
  49. ncbi request reprint Effectiveness of the sirolimus-eluting stent in the treatment of patients with a prior history of coronary artery bypass graft surgery
    Angela Hoye
    Department of Cardiology, Thoraxcenter, Erasmus Medical Centre, Rotterdam, The Netherlands
    Coron Artery Dis 15:171-5. 2004
    ..We evaluated the impact of utilizing the sirolimus-eluting stent (SES) in this high-risk population...
  50. ncbi request reprint Geographical miss and restenosis during catheter-based intracoronary beta-radiation for de novo lesions
    Georgios Sianos
    Department of Interventional Cardiology, Erasmus MC Rotterdam, Thoraxcenter Bd 404, Dr Molewaterplein 40, 3015 GD Rotterdam, The Netherlands
    Cardiovasc Radiat Med 3:138-46. 2002
    ..We sought to determine the impact of geographical miss (GM) on restenosis rates after intracoronary beta-radiation therapy for de novo lesions...
  51. ncbi request reprint Retrograde recanalization of chronically occluded coronary arteries: illustration and description of the technique
    Neville Kukreja
    Department of Interventional Cardiology, Thoraxcenter, Erasmus Medical Center, Rotterdam, The Netherlands
    Catheter Cardiovasc Interv 69:833-41. 2007
    ..One method, which may improve technical success rates, is the use of a retrograde approach. We report three cases employing a retrograde approach and describe the technique in detail...
  52. ncbi request reprint Short- and long-term clinical benefit of sirolimus-eluting stents compared to conventional bare stents for patients with acute myocardial infarction
    Pedro A Lemos
    Erasmus Medical Center, Thoraxcenter, Rotterdam, Netherlands
    J Am Coll Cardiol 43:704-8. 2004
    ..This study investigated the clinical outcomes of patients with ST-segment elevation myocardial infarction (MI) treated with sirolimus-eluting stents (SESs) or with conventional bare stents...
  53. ncbi request reprint Effectiveness of sirolimus-Eluting stent implantation for coronary narrowings <50% in diameter
    Angela Hoye
    Erasmus Medical Center, Thoraxcenter, Rotterdam, The Netherlands
    Am J Cardiol 94:112-4. 2004
    ..At a mean follow-up of 399 +/- 120 days, the survival-free of major adverse events was 95%, with no patient requiring target lesion revascularization...
  54. ncbi request reprint Clinical outcomes for sirolimus-eluting stent implantation and vascular brachytherapy for the treatment of in-stent restenosis
    Francesco Saia
    Thoraxcenter, Erasmus University Medical Center, Rotterdam, The Netherlands
    Catheter Cardiovasc Interv 62:283-8. 2004
    ..1% VBT vs. 81.5% SES; P = 0.8 by log rank). The result of this nonrandomized study suggests that sirolimus-eluting stent implantation is at least as effective as vascular brachytherapy in the treatment of in-stent restenosis...
  55. ncbi request reprint Stent fracture and restenosis of a paclitaxel-eluting stent
    Michalis I Hamilos
    Department of Interventional Cardiology, Thoraxcenter, Erasmus Medical Center, Rotterdam, The Netherlands
    Hellenic J Cardiol 46:439-42. 2005
    ..Fracture is an unusual and probably underestimated cause of restenosis, which acquires special significance in this era of drug-eluting stents...
  56. ncbi request reprint The effect of variable dose and release kinetics on neointimal hyperplasia using a novel paclitaxel-eluting stent platform: the Paclitaxel In-Stent Controlled Elution Study (PISCES)
    Patrick W Serruys
    Erasmus Medical Center, Rotterdam, The Netherlands
    J Am Coll Cardiol 46:253-60. 2005
    ..The aim of this study was to evaluate the effect of variable dose and release kinetics of paclitaxel on neointimal hyperplasia...
  57. ncbi request reprint "Full metal jacket" (stented length > or =64 mm) using drug-eluting stents for de novo coronary artery lesions
    Jiro Aoki
    Erasmus Medical Center, Thoraxcenter, Rotterdam, The Netherlands
    Am Heart J 150:994-9. 2005
    ..quot;..
  58. ncbi request reprint Indication of long-term endothelial dysfunction after sirolimus-eluting stent implantation
    Sjoerd H Hofma
    Department of Cardiology, Thoraxcenter, Erasmus MC, Bd 412, Dr Molewaterplein 40, 3015 GD Rotterdam, The Netherlands
    Eur Heart J 27:166-70. 2006
    ..We assessed local epicardial endothelial function 6 months after sirolimus-eluting stent (SES) or bare metal stent (BS) implantation...
  59. doi request reprint Four-year clinical outcome of sirolimus- and paclitaxel-eluting stents compared to bare-metal stents for the percutaneous treatment of stable coronary artery disease
    Cihan Simsek
    Department of Cardiology, Thoraxcenter, Erasmus Medical Center Rotterdam, Dr Molewaterplein 40, Rotterdam, The Netherlands
    Catheter Cardiovasc Interv 76:41-9. 2010
    ..There are limited data on the long-term safety and efficacy profile of coronary stent implantation in patients with stable coronary artery disease (CAD) undergoing percutaneous coronary intervention (PCI)...
  60. ncbi request reprint Effectiveness of sirolimus-eluting stent implantation for the treatment of coronary artery disease in octogenarians
    Maniyal Vijayakumar
    Erasmus Medical Center, Thoraxcenter, Rotterdam, The Netherlands
    Am J Cardiol 94:909-13. 2004
    ..SES implantation in octogenarians appears to be feasible and is associated with very small subsequent need for repeat target vessel revascularization at 1 year...
  61. ncbi request reprint Actinomycin-eluting stent for coronary revascularization: a randomized feasibility and safety study: the ACTION trial
    Patrick W Serruys
    Erasmus Medical Center, Rotterdam, The Netherlands
    J Am Coll Cardiol 44:1363-7. 2004
    ..We sought to demonstrate the safety and performance of the actinomycin D-coated Multilink-Tetra stent(Guidant Corp., Santa Clara, California) in the treatment of patients with single de novo native coronary lesions...
  62. ncbi request reprint Value of preprocedure multislice computed tomographic coronary angiography to predict the outcome of percutaneous recanalization of chronic total occlusions
    Nico R Mollet
    Department of Cardiology, Thoraxcenter, Erasmus Medical Center, PO Box 2040, 3000 CA Rotterdam, The Netherlands
    Am J Cardiol 95:240-3. 2005
    ..Multivariate analysis identified a blunt stump (by conventional angiography), occlusion length >15 mm, and severe calcification (by multislice computed tomographic coronary angiography) as independent predictors of procedural failure...
  63. ncbi request reprint Rationale and methods of the integrated biomarker and imaging study (IBIS): combining invasive and non-invasive imaging with biomarkers to detect subclinical atherosclerosis and assess coronary lesion biology
    Carlos A G van Mieghem
    Erasmus Medical Center, Thoraxcenter, Rotterdam, The Netherlands
    Int J Cardiovasc Imaging 21:425-41. 2005
    ..It outlines the analyses that will be performed to compare invasive and non-invasive imaging techniques in conjunction with multiple biomarkers to characterize non-flow limiting subclinical coronary lesions...
  64. ncbi request reprint Direct stenting versus direct stenting followed by centered beta-radiation with intravascular ultrasound-guided dosimetry and long-term anti-platelet treatment: results of a randomized trial: Beta-Radiation Investigation with Direct Stenting and Galileo i
    Patrick W Serruys
    Erasmus Medical Center, Rotterdam, The Netherlands
    J Am Coll Cardiol 44:528-37. 2004
    ..We sought to assess the efficacy of vascular brachytherapy (VBT) combined with stenting for the primary prevention of restenosis...
  65. ncbi request reprint Immediate and one-year outcome of percutaneous intervention of saphenous vein graft disease with paclitaxel-eluting stents
    Keiichi Tsuchida
    Department of Interventional Cardiology, Thoraxcenter, Erasmus Medical Center, Rotterdam, The Netherlands
    Am J Cardiol 96:395-8. 2005
    ..5%. A paclitaxel-eluting stent for saphenous vein graft disease appears to be feasible and safe, with a low rate of reintervention at 1 year, but late follow-up is needed to confirm these observations...
  66. ncbi request reprint Elective sirolimus-eluting stent implantation for multivessel disease involving significant LAD stenosis: one-year clinical outcomes of 99 consecutive patients--the Rotterdam experience
    Chourmouzios A Arampatzis
    Department of Interventional Cardiology, Thoraxcenter, Erasmus Medical Center, Rotterdam, The Netherlands
    Catheter Cardiovasc Interv 63:57-60. 2004
    ..6%. SES implantation for multivessel disease in a consecutive series of patients is associated with low incidence of adverse events. The reported results are related predominantly to the reduction in repeat revascularization...
  67. ncbi request reprint Sirolimus-eluting stents for the treatment of atherosclerotic ostial lesions
    Maniyal Vijayakumar
    Thoraxcenter, Erasmus Medical Center, Rotterdam, The Netherlands
    J Invasive Cardiol 17:10-2. 2005
    ..Various stent designs have failed to show significant improvement in target lesion revascularization (TLR) rates. The present study evaluates the clinical outcomes following sirolimus-eluting stent implantation for ostial lesions...
  68. ncbi request reprint Stent fracture and restenosis in the drug-eluting stent era
    Georgios Sianos
    Department of Interventional Cardiology, Thoraxcenter, Erasmus MC, Rotterdam, The Netherlands
    Catheter Cardiovasc Interv 61:111-6. 2004
  69. ncbi request reprint Unrestricted utilization of sirolimus-eluting stents compared with conventional bare stent implantation in the "real world": the Rapamycin-Eluting Stent Evaluated At Rotterdam Cardiology Hospital (RESEARCH) registry
    Pedro A Lemos
    Erasmus Medical Center, Thoraxcenter, Rotterdam, The Netherlands
    Circulation 109:190-5. 2004
    ..The effectiveness of sirolimus-eluting stents in unselected patients treated in the daily practice is currently unknown...
  70. ncbi request reprint Improved recanalization of chronic total coronary occlusions using an optical coherence reflectometry-guided guidewire
    Angela Hoye
    Department of Interventional Cardiology, Thoraxcentre, Erasmus MC, Rotterdam, The Netherlands
    Catheter Cardiovasc Interv 63:158-63. 2004
    ..7%), with no complications of tamponade, myocardial infarction, or death. These results demonstrate that this wire can be a useful tool in addition to conventional wires in the treatment of CTO...
  71. ncbi request reprint A randomised controlled study comparing conventional and magnetic guidewires in a two-dimensional branching tortuous phantom simulating angulated coronary vessels
    Steve Ramcharitar
    Thoraxcenter, Erasmus Medical Center, Rotterdam, Netherlands
    Catheter Cardiovasc Interv 70:662-8. 2007
    ..To directly compare the magnetic navigation system (MNS) guidewires with conventional guidewires in branching tortuous phantoms with operators of varying MNS and percutaneous coronary intervention experience...
  72. ncbi request reprint Long-term outcome of percutaneous coronary interventions following failed beta-brachytherapy
    Francesco Saia
    Department of Interventional Cardiology, Thoraxcenter, Erasmus Medical Center, Rotterdam, The Netherlands
    J Invasive Cardiol 16:60-4. 2004
    ..The long-term outcome of repeat percutaneous intervention (PCI) after failed beta-brachytherapy is currently unknown...
  73. ncbi request reprint Effectiveness of the sirolimus-eluting stent in the treatment of saphenous vein graft disease
    Angela Hoye
    Department of Cardiology, Thoraxcenter, Erasmus Medical Center, Rotterdam, The Netherlands
    J Invasive Cardiol 16:230-3. 2004
    ..Increased utilization of distal protection devices might reduce the peri-procedural rate of AMI...
  74. ncbi request reprint Noninvasive detection of subclinical coronary atherosclerosis coupled with assessment of changes in plaque characteristics using novel invasive imaging modalities: the Integrated Biomarker and Imaging Study (IBIS)
    Carlos A G van Mieghem
    Erasmus Medical Center, Rotterdam, The Netherlands
    J Am Coll Cardiol 47:1134-42. 2006
    ..Our purpose was to assess noninvasive imaging in detection of subclinical atherosclerosis and to examine novel invasive modalities to describe prevalence and temporal changes in putative characteristics of "high-risk" plaques...
  75. ncbi request reprint No change in endothelial-dependent vasomotion late after coronary irradiation
    Sjoerd H Hofma
    Department of Cardiology, Thoraxcenter, Erasmus Medical Center, Rotterdam, The Netherlands
    Cardiovasc Radiat Med 5:156-61. 2004
    ..This study was conducted to assess endothelial function late after the irradiation of atherosclerotic coronary arteries...
  76. ncbi request reprint Guidewire navigation in coronary artery stenoses using a novel magnetic navigation system: first clinical experience
    Keiichi Tsuchida
    Department of Interventional Cardiology, Thoraxcenter, Erasmus Medical Center, Rotterdam, The Netherlands
    Catheter Cardiovasc Interv 67:356-63. 2006
    ..Clinical studies are needed to evaluate the potential benefit of the MNS in more complex coronary lesions and tortuous anatomy...
  77. ncbi request reprint Routine intracoronary beta-irradiation. Acute and one year outcome in patients at high risk for recurrence of stenosis
    E Regar
    Department for Cardiology, Thoraxcenter, University Hospital Rotterdam, The Netherlands
    Eur Heart J 23:1038-44. 2002
    ..Currently, only limited data on this treatment are available. The feasibility and outcome in daily routine practice, however, is unknown...
  78. ncbi request reprint Evaluation of left ventricular function and volumes in patients with ischaemic cardiomyopathy: gated single-photon emission computed tomography versus two-dimensional echocardiography
    E C Vourvouri
    Department of Cardiology, Thoraxcenter, Erasmus Medical Center Rotterdam, Dr. Molewaterplein 40, 3015 GD Rotterdam, The Netherlands
    Eur J Nucl Med 28:1610-5. 2001
    ....
  79. ncbi request reprint Perioperative tissue Doppler echocardiography and bypass graft flowmetry in patients undergoing coronary revascularization: predictive power for late recovery of regional myocardial function
    R Ian Williams
    Cardiovascular Sciences Research Group, University of Wales College of Medicine, Cardiff, UK
    J Am Soc Echocardiogr 15:1202-10. 2002
    ..Perioperative changes in resting myocardial systolic velocity are highly variable and do not predict late recovery...
  80. ncbi request reprint Impact of baseline renal function on mortality after percutaneous coronary intervention with sirolimus-eluting stents or bare metal stents
    Pedro A Lemos
    Heart Institute InCor, University of Sao Paulo Medical School, Sao Paulo, Brazil
    Am J Cardiol 95:167-72. 2005
    ..It seems unlikely that restenosis could be a contributing factor that influenced the increased mortality of patients who had impaired renal function...